Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:582351.
doi: 10.5402/2011/582351. Epub 2011 Dec 27.

Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs

Brigitte M Richard  1 , Douglas E Rickert, Dannette Doolittle, Amy Mize, Jason Liu, Charles F Lawson
Affiliations

Pharmacokinetic Compatibility Study of Lidocaine with EXPAREL in Yucatan Miniature Pigs

Brigitte M Richard et al. ISRN Pharm. 2011.

Abstract

We explored the potential for EXPAREL to interact with lidocaine. Sixty (60) male Yucatan Swine were randomized into 20 groups (N = 3/group). EXPAREL (2 or 4 mg/kg) and/or lidocaine HCl solution 1% or 2% (with epinephrine 1 : 200,000) were injected subcutaneously along a 5 cm virtual incision line. The effects on the pharmacokinetics of bupivacaine and lidocaine were examined when 5, 10, 20, and 40 minutes had passed between administration of lidocaine and EXPAREL. Systemic exposure to lidocaine was increased (AUC(0-24 hr) by 48%; C(max) by 1,640%) when lidocaine (4 mg/kg) was followed 5 minutes later by EXPAREL (4 mg/kg) compared to lidocaine administered alone. Plasma bupivacaine was increased (AUC(0-24 hr) by 50-95%; C(max) by 67-1,000%) when lidocaine (4 mg/kg) was followed 5 or 10 minutes later by EXPAREL (4 mg/kg) compared to EXPAREL alone. While EXPAREL should not be admixed with lidocaine, this study shows that local administration of EXPAREL after at least 20 minutes following local administration of lidocaine did not increase the release of either drug.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram showing the dose equally distributed as 6 serial bolus injections along a 5 cm virtual incision line.
Figure 2
Figure 2
Diagram showing the approximate area where subcutaneous injections were administered on each animal (i.e., scapular region).
Figure 3
Figure 3
Mean systemic exposure parameters (±SD) for plasma lidocaine (a) and bupivacaine (b) after high (4 mg/kg) subcutaneous dose of lidocaine/epinephrine and EXPAREL (N = 3/group unless noted). Series 1: AUC0−24 hr (ng/mL·hr). Series 2: C max⁡ (ng/mL). Notes: SD was not calculated for mean plasma bupivacaine concentrations at 5 minutes (N = 2) because one animal received 55% of the intended dose of EXPAREL; therefore, data from this animal were not used in calculation of means; individual values for AUC0−24 hr = 2,980 and 5,770 ng/mL·hr and for C max⁡ = 3,690 and 7,770 ng/mL.
Figure 4
Figure 4
Mean systemic exposure parameters (±SD) for plasma lidocaine after high (4 mg/kg) subcutaneous dose of lidocaine/epinephrine and EXPAREL (N = 3/group).
Figure 5
Figure 5
Systemic exposure parameters (±SD) for plasma bupivacaine after high (4 mg/kg) subcutaneous dose of lidocaine/epinephrine and EXPAREL (N = 3/group unless noted). Notes: SD was not calculated for bupivacaine at 5 minutes (N = 2, AUC = 2,980 and 5,770 ng/mL·h; C max⁡ = 3,690 and 7,770 ng/mL).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Angst MS, Drover DR. Pharmacology of drugs formulated with DepoFoam®: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology. Clinical Pharmacokinetics. 2006;45(12):1153–1176. - PubMed
    1. DepoDur® (morphine sulfate extended- release liposome injection) Pacira Pharmaceuticals Inc., 2008, http://www.drugs.com/pro/depodur.html.
    1. DuocaineTM USPI (lidocaine HCl—bupivacaine HCl injection) 1% / 0.375% Amphastar Pharmaceuticals Inc., 2009, http://www.drugs.com/pro/duocaine.html.
    1. Cuvillon P, Nouvellon E, Ripart J, et al. A comparison of the pharmacodynamics and pharmacokinetics of bupivacaine, ropivacaine (with epinephrine) and their equal volume mixtures with lidocaine used for femoral and sciatic nerve blocks: a double-blind randomized study. Anesthesia and Analgesia. 2009;108(2):641–649. - PubMed
    1. Bernards CM, Kopacz DJ. Effect of epinephrine on lidocaine clearance in vivo: a microdialysis study in humans. Anesthesiology. 1999;91(4):962–968. - PubMed

LinkOut - more resources